Table 1 Clinic-pathological characteristics of enrolled patients.

From: PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability

Clinicopathological characteristics

Total (n = 30)

PTBP3

Higha (n = 15)

lowa (n = 15)

P value

Mean age

63.5 ± 1.853

66.07 ± 2.792

60.93 ± 2.343

0.17

Sex

   

0.6903

Male

21

11

10

 

Female

9

4

5

 

Tumor site

   

0.3940

Left colon

1

0

1

 

Right colon

12

5

7

 

Rectum

17

10

7

 

Staging

   

0.2557

I–II

19

11

8

 

III–IV

11

4

7

 

Tumor size

   

0.0464*

≥5 cm

11

7

2

 

<5 cm

19

8

13

 

Differentiation

 

0.9103

  

CRC,WD

9

5

4

 

CRC,MD

13

6

7

 

CRC,PD

8

4

4

 

Tumor stage

   

>0.9999

T1–T2

8

4

4

 

T3–T4

22

11

11

 

Lymph node

   

0.0803

N0

19

11

8

 

N1

7

1

6

 

N2

4

3

1

 

Distant metastasis

   

0.3091

M0

29

15

14

 

M1

1

0

1

 
  1. *Statistical significance was determined by Chi-squared test, P < 0.05.
  2. aLow and high expression groups were determined by the cutoff-point 50% (15 of 30) and 50% (15 of 30) of PTBP3 in 30 tumor tissue specimens.
Back to article page